CUA Educational Content

CUA Speaker Tour: Theragnostics


Featuring: Michael Hofman (PET Modality Lead, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging)

 
SESSION #1: PSMA Imaging: When should I use it and what are the pitfalls?

SESSION #2: Evidence-base for radiopharmaceuticals: Life-prolonging therapies for men with prostate cancer

SESSION #3: Next generation PSMA theragnostics: What is coming next?

Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

This program has received financial support from Abbvie and Bayer in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy